Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Eniluracil (GW776C85) is an orally activedihydropyrimidine dehydrogenase (DPD) inhibitor,increases the oral bioavailability of 5-FU to 100%, facilitating uniform absorption and predictable toxicity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | In stock | $ 41.00 | |
25 mg | In stock | $ 76.00 | |
50 mg | In stock | $ 124.00 | |
100 mg | In stock | $ 185.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 45.00 |
Description | Eniluracil (GW776C85) is an orally activedihydropyrimidine dehydrogenase (DPD) inhibitor,increases the oral bioavailability of 5-FU to 100%, facilitating uniform absorption and predictable toxicity. |
Synonyms | GW776C85, 5-Ethynyluracil |
Molecular Weight | 136.11 |
Formula | C6H4N2O2 |
CAS No. | 59989-18-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 62.5 mg/mL (459.19 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Eniluracil 59989-18-3 Others 5-fluorouracil cancer Inhibitor inhibit GW776C85 5-FU 5-Ethynyluracil tumor combination inhibitor